BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32927105)

  • 21. Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease.
    Damrath JG; Moe SM; Wallace JM
    J Bone Miner Res; 2022 Jul; 37(7):1297-1306. PubMed ID: 35593150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.
    Vorland CJ; Lachcik PJ; Swallow EA; Metzger CE; Allen MR; Chen NX; Moe SM; Hill Gallant KM
    Sci Rep; 2019 May; 9(1):7936. PubMed ID: 31138895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.
    Rodenbeck SD; Zarse CA; McKenney-Drake ML; Bruning RS; Sturek M; Chen NX; Moe SM
    Nephrol Dial Transplant; 2017 Mar; 32(3):450-458. PubMed ID: 27510531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracking changes of individual cortical pores over 1 year via HR-pQCT in a small cohort of 60-year-old females.
    Surowiec RK; Swallow EA; Warden SJ; Allen MR
    Bone Rep; 2022 Dec; 17():101633. PubMed ID: 36337684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
    Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
    Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
    Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
    Vorland CJ; Biruete A; Lachcik PJ; Srinivasan S; Chen NX; Moe SM; Hill Gallant KM
    J Bone Miner Res; 2020 Feb; 35(2):333-342. PubMed ID: 31618470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
    Surowiec RK; Saldivar R; Rai RK; Metzger CE; Jacobson AM; Allen MR; Wallace JM
    Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.
    Tatsumoto N; Arioka M; Yamada S; Takahashi-Yanaga F; Tokumoto M; Tsuruya K; Kitazono T; Sasaguri T
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27803315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
    Mohamed FF; Amadeu de Oliveira F; Kinoshita Y; Yalamanchili RR; Eltilib LA; Andras NL; Narisawa S; Tani T; Chu EY; Millán JL; Foster BL
    J Bone Miner Res; 2023 Aug; 38(8):1192-1207. PubMed ID: 37191192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet.
    Zaloszyc A; Choquet P; Sayeh A; Bartosova M; Schaefer B; Huegel U; Aubertin-Kirch G; Healy C; Severac F; Rizzo S; Boivin G; Schaefer F; Fischbach M; Bacchetta J; Bahram S; Schmitt CP
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties.
    Lotinun S; Evans GL; Bronk JT; Bolander ME; Wronski TJ; Ritman EL; Turner RT
    J Bone Miner Res; 2004 Jul; 19(7):1165-71. PubMed ID: 15177000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications.
    Ikeda R; Imai Y; Maruyama W; Mizoguchi K
    Nephrology (Carlton); 2010 Feb; 15(1):54-62. PubMed ID: 20377772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteocytes' expression of the PTH/PTHrP receptor has differing effects on endocortical and periosteal bone formation during adenine-induced CKD.
    Gardinier JD; Daly-Seiler CS; Zhang C
    Bone; 2020 Apr; 133():115186. PubMed ID: 31987988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease.
    Wójtowicz M; Piechota W; Wańkowicz Z; Smoszna J; Niemczyk S
    Med Sci Monit; 2020 Dec; 26():e928301. PubMed ID: 33361742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.
    Geng S; Kuang Z; Peissig PL; Page D; Maursetter L; Hansen KE
    Osteoporos Int; 2019 Oct; 30(10):2019-2025. PubMed ID: 31190122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.